Lili Yang, Ph.D., Professor University of California, Los Angeles (UCLA)   Short Bio- Dr. Lili Yang received her Ph.D. degree in Biology from the California Institute of Technology (Caltech), studying with Dr. David Baltimore. She is currently Professor of Microbiology, Immunology and Molecular Genetics at the University of California, Los Angeles (UCLA). Her research laboratory at UCLA studies tumor immunology and cancer immunotherapy, with a special focus on developing gene and cell-based immunotherapy for cancer (https://www.liliyanglab.com/). So far her work has resulted in over 100 publications, 28 patents, 2 clinical trials, and 2 biotech startups.      In recognition of her scientific achievements, Dr. Lili Yang has received multiple prestigious awards, including a TR35 (Innovators Under 35) Award from the MIT Technology Review Magazine, a Director’s New Innovator Award from the National Institute of Health (NIH), a Young Investigator Award from the American Association of Immunologists (AAI), and an Outstanding New Investigator Award from the American Society of Gene & Cell Therapy (ASGCT).   Dr. Lili Yang is also widely recognized for her biotech accomplishments. She has been named Women in Biopharma by Endpoints News in 2022, and Top Women in Academic Entrepreneurship by BIOS in 2023.